Medpace Holdings, Inc. Financials

Market Capitalization $10.81 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	30.49
Forward PE	27.85
Price to Sales TTM	$5.22
Price to Book MRQ	$12.24
Enterprise to Revenue	4.97
Enterprise to EBITDA	23.51

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	17.66%
Operating Margin	21.05%
Return on Assets TTM	14.31%
Return on Equity TTM	54.08%

Income Statement

Revenue TTM	$2,070,866,048
Revenue per Share TTM	$67.02
Quarterly Revenue Growth	8.30%
Gross Profit TTM	$1,392,002,048
EBITDA	$439,727,000
Net Income to Common TTM	$365,572,000
Diluted EPS TTM	$11.41
Quarterly Earnings Growth YoY	36.70%

Balance Sheet

Total Cash MRQ	$656,899,968
Total Cash per Share MRQ	$21.18
Total Debt MRQ	$
Total Debt to Equity MRQ	17.23
Current Ratio MRQ	0.99
Book Value per Share MRQ	$28.42

Cash Flow

Operating Cash Flow TTM	$574,544,000
Levered Free Cash Flow TTM	$437,600,512

MEDP Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	31,081,600
Float Shares	25,474,110
Avg 10 Volume	233,310
Avg 30 Volume	None
Shares Short	1,154,352
Short Ratio	4.77
Short % of Shares	5.57%
% Held by Insiders	17.83%
% Held by Institutions	85.62%

Stock Price Summary

Beta	1.37
Fifty Two Week Low	$286.76
Fifty Two Week High	$459.77
Fifty Two Week Change	12.42%
Day 50 MA	$341.22
Day 200 MA	$368.96

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date